Generic Drugs

2026 Leading Generic Drug Companies Capabilities, Goals and Strategies

Tue, 01 Aug 2023 13:13:19 +0000

This report is part of the Competitive Analysis Series prepared by LeadingMarketResearch.com to help current suppliers and potential market entrants realistically assess their financial, technological and marketing capabilities in relation to the leading competitors.

The series includes current assessments of more than 1,000 companies worldwide. Depending on the company’s business nature and structure, the assessments include all or some of the following analyses: Organization and Management, Acquisitions and Divestitures, Facilities and Employees, Research and Development, Technological Know-How, Key Products, Marketing Capabilities, Financial Results, Strengths and Weaknesses, and Strategic Directions. ...

$2,450.00

Leading Generic Drug Companies SWOT Analysis--Capabilities, Goals and Strategies

Mon, 23 Aug 2021 14:59:05 +0000

$4,500.00

Generics in Indonesia

Wed, 26 Feb 2020 12:43:15 +0000

Summary

Generics in Indonesia industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Indonesian generics market had total revenues of $1.2bn in 2018, representing a compound annual growth rate (CAGR) of 15.5% between 2014 and 2018.
- Market consumption volume increased with a CAGR of 0.2% between 2014 and 2018, to reach 47.9% of total pharma volume.
- In 2014, Indonesia l...

$350.00

Global Anticoagulant Drugs Market Research Report 2019-2023

Mon, 11 Nov 2019 13:49:04 +0000

Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Anticoagulant Drugs Report by Material, Application, and Geography – Global Forecast to 2023 is a professional and comprehensive research report on the world’s major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom, Japan, South Korea and China). In this report, the global Anticoagulant Drugs market is valued at USD XX million in 2019 and is projected to reach USD XX million by the end of 2023, growing at a CAGR of XX% during the period 2019 to 2023. The report firstly introduced the Anticoagulant Drugs basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the wor...

$2,850.00

Generic Drugs Leading Companies Capabilities, Goals and Strategies

Mon, 09 Sep 2019 13:52:25 +0000

$1,950.00

Generic Drugs Market Intelligence: Leading Companies Capabilities, Goals and Strategies

Tue, 18 Jun 2019 12:01:54 +0000

$2,750.00

Generic Drugs Markets in China

Wed, 09 May 2018 11:25:43 +0000

China's demand for Generic Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2007, 2012 and 2017) and long-term forecasts through 2022 and 2027 are presented. Major producers in China are profiled. The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and our in-house databases. Interviews are conducte...

$4,000.00

Generic Drugs Industry Forecasts - China Focus

Wed, 09 May 2018 11:25:43 +0000

This study focuses on China’s Generic Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market. Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering from minimal innovation a...

$1,800.00

Generic Drugs Companies in China

Wed, 09 May 2018 11:25:43 +0000

This study focuses on China’s Generic Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world’s fastest growing market for the consumptions of goods and services. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. Rapid consolidation between medium and large players is anticipated since the Chinese government has been encouraging industry consolidation with an effort to regulate the industry and to improve competitiveness in the world market. Although China has enjoyed the benefits of an expanding market for production and distribution, the industry is suffering fr...

$1,800.00

The Future of Generic Drugs and Strategies for Commercial Success

Fri, 28 Apr 2017 13:33:55 +0000

Summary

GBI Research’s latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic drug companies around the world. GBI Research conducted an extensive and targeted industry survey of experts from top global generic drug companies, to gather opinions on the trends and future commercial prospects of the generic drugs market. The findings from the survey and results from extensive data analysis and secondary research efforts have been triangulated with GBI’s own analytical views to provide an objective assessment that is comprehensive in outlook.

The generic drugs market has seen rapid expansion for more than 30 years, and consistently achieves higher annual growth rates than the overall pharmaceutical market. The increase in generic drug activity can be primarily attributed to the promise of significant revenues from blockbuster drugs nearing patent expiry. In the US – the largest generic drugs market b...

$2,995.00

Generics Global Industry Almanac-2017

Thu, 30 Mar 2017 12:00:30 +0000

Summary

Global Generics industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the global generics market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies.

- For the purposes of this profile, a generic is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The market value is evaluated at ex-factory prices.
- Market volume is quantified here as the perce...

$2,995.00

Generics Global Group of Eight (G8) Industry Guide-2017

Thu, 30 Mar 2017 12:00:30 +0000

Summary

The G8 Generics industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Essential resource for top-line data and analysis covering the G8 generics market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies.

- The G8 countries contributed $189.4 billion in 2016 to the global generics industry, with a compound annual growth rate (CAGR) of 10.9% between 2012 and 2016. The G8 countries are expected to reach a value of $384.0 billion in 2021, with a CAGR of 15.2% over the 2016-21 period.
- Among the G8 nations, the US is the leading country in the generics industry, with market revenues of $99.7 billion in 2016. This was followed by Japan and Germany, with a value of $56.6 and $8.5 billion, respectively.
- Japan is...

$1,495.00